Piper Sandler
- Market cap
- 4.29B
- P/E (TTM)i
- 14.78
- P/Bi
- 3.12
- EPSi
- 3.96
- Div yieldi
- 1.14%
- 52W posi
- 4%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.5 percentage points.
Institutional ownership
- Held by institutions
- 93.31% +0.50pp
- Institutions
- 488 -3
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 42 buys · 7 sells
| Name | Role | Stake |
|---|---|---|
| Jonathan Doyle | Vice Chairman, Senior Managing Principal & Head of Financial Services Group | 0.71% |
| James Baker | MD and Global Co-Head of Investment Banking & Capital Markets | 0.70% |
| Chad Abraham | Chairperson & CEO | 0.62% |
| Debbra Schoneman | President & MD | 0.38% |
| Jean-Paul Peltier | MD & Global Group Head of Healthcare Investment Banking | 0.22% |
| Brian Sterling | Director | 0.16% |
| Michael Dillahunt | Global Co-Head of Investment Banking & Capital Markets | 0.15% |
| Philip Soran | Lead Independent Director | 0.12% |
| John Geelan | MD, General Counsel & Secretary | 0.08% |
| Katherine Clune | Chief Financial Officer | 0.07% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Philip Soran | Lead Independent Director | Other Acquisition | +383 | -- |
| 2026-09-29 | Brian Sterling | Director | Other Acquisition | +383 | -- |
| 2026-09-29 | Ann Gallo | Director | Other Acquisition | +383 | -- |
| 2026-09-21 | Wendy Schoppert | Director | Other Acquisition | +1,396 | -- |
| 2026-09-21 | Wendy Schoppert | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-09-10 | Philip Soran | Lead Independent Director | Other Acquisition | +214 | -- |
| 2026-09-10 | Victoria Holt | Independent Director | Other Acquisition | +79 | -- |
| 2026-09-10 | Brian Sterling | Director | Other Acquisition | +33 | -- |
| 2026-09-10 | Scott Taylor | Independent Director | Other Acquisition | +91 | -- |
| 2026-09-10 | Robbin Mitchell | Independent Director | Other Acquisition | +42 | -- |
| 2026-09-10 | Ann Gallo | Director | Other Acquisition | +22 | -- |
| 2026-06-29 | Philip Soran | Lead Independent Director | Other Acquisition | +345 | -- |
| 2026-06-29 | Brian Sterling | Director | Other Acquisition | +345 | -- |
| 2026-06-29 | Ann Gallo | Director | Other Acquisition | +345 | -- |
| 2026-06-11 | Philip Soran | Lead Independent Director | Other Acquisition | +206 | -- |
| 2026-06-11 | Victoria Holt | Independent Director | Other Acquisition | +76 | -- |
| 2026-06-11 | Brian Sterling | Director | Other Acquisition | +31 | -- |
| 2026-06-11 | Scott Taylor | Independent Director | Other Acquisition | +87 | -- |
| 2026-06-11 | Robbin Mitchell | Independent Director | Other Acquisition | +40 | -- |
| 2026-06-11 | Ann Gallo | Director | Other Acquisition | +20 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:00:15 · For reference only, not investment advice and not tailored to your situation.